Medicines for Malaria Venture (MMV) Revenue and Competitors

Geneva,

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Medicines for Malaria Venture (MMV)'s estimated annual revenue is currently $3.5M per year.(i)
  • Medicines for Malaria Venture (MMV)'s estimated revenue per employee is $17,677

Employee Data

  • Medicines for Malaria Venture (MMV) has 198 Employees.(i)
  • Medicines for Malaria Venture (MMV) grew their employee count by 3% last year.

Medicines for Malaria Venture (MMV)'s People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VPReveal Email/Phone
3
VP, Head DiscoveryReveal Email/Phone
4
EVP, Access and Product ManagementReveal Email/Phone
5
VP, Pharmaceutical DevelopmentReveal Email/Phone
6
VP, Head External RelationsReveal Email/Phone
7
EVP, Head Human ResourcesReveal Email/Phone
8
EVP, Business DevelopmentReveal Email/Phone
9
VP, Head Product DevelopmentReveal Email/Phone
10
Associate Director, External RelationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$35M21834%N/AN/A
#2
$15M3284%N/AN/A
#3
$15M1119%N/AN/A
#4
$750M199040%N/AN/A
#5
$15M841%N/AN/A
#6
$7.5M30-6%N/AN/A
#7
$7.5M11515%N/AN/A
#8
$7.5M552%N/AN/A
#9
$7.5M10115%N/AN/A
#10
N/A174912%N/AN/A
Add Company

What Is Medicines for Malaria Venture (MMV)?

MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria

keywords:N/A

N/A

Total Funding

198

Number of Employees

$3.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medicines for Malaria Venture (MMV) News

2022-03-22 - Australian TGA approves pediatric tafenoquine

... partnership with Medicines for Malaria Venture (MMV) to facilitate use in children, who are disproportionately affected by the disease.

2022-03-22 - Single-dose malaria drug for children, tafenoquine, receives approval in Australia

... 5.1 million infections a year, according to the nonprofit Medicines for Malaria Venture (MMV), which helped develop the new treatment.

2022-03-22 - New Malaria Treatment Gets First Approval for Use in Children

... A new drug that can cure a certain type of malaria was approved in ... on Monday by the nonprofit Medicines for Malaria Venture (MMV),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$300M20031%N/A
#2
$35M2414%N/A
#3
$3.5M25526%N/A
#4
$77.5M2610%N/A
#5
$60.5M2621%N/A